Nuvation Bio NUVB
NYSE NUVB
$5.38 -0.18 (-3.24%)
As of: Oct 2, 2026 · 9:58 AM EDT

Nuvation Bio (NUVB) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Nuvation Bio (NUVB) posted Depreciation & Amortization (CF) of $536,000 for Q2 2026, up 50.6% from $356,000 a year earlier and unchanged from the prior quarter.

Analysis

Nuvation Bio (NUVB) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Nuvation Bio was $2.15 million, up 104.9% year-over-year; for FY2025, it was $1.74 million, up 154.6% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for three consecutive years, with a five-year compound annual growth rate of 76.0% (FY2020 to FY2025).
  • In prior years, Nuvation Bio's Depreciation & Amortization (CF) was $683,000 in FY2024 (+207.7%), $222,000 in FY2023 (+11.0%), $200,000 in FY2022 (unchanged) and $200,000 in FY2021 (+94.2%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $46,000 in Q1 2022 to a high of $539,000 in Q4 2025 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last 11 quarters, with growth averaging 184.0% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2025, with growth of 434.5%; the weakest was Q3 2022, with a decline of 20.0%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $536,000 (Q1 2026), $539,000 (Q4 2025) and $534,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Nuvation Bio 1.94 Bn 1.94 Bn - 536,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 536,000.00
Mar 31, 2026 536,000.00
Dec 31, 2025 539,000.00
Sep 30, 2025 534,000.00
Jun 30, 2025 356,000.00
Mar 31, 2025 310,000.00
Dec 31, 2024 219,000.00
Sep 30, 2024 162,000.00
Jun 30, 2024 244,000.00
Mar 31, 2024 58,000.00
Dec 31, 2023 55,000.00
Sep 30, 2023 55,000.00
Jun 30, 2023 56,000.00
Mar 31, 2023 56,000.00
Dec 31, 2022 50,000.00
Sep 30, 2022 56,000.00
Jun 30, 2022 48,000.00
Mar 31, 2022 46,000.00
Dec 31, 2021 59,000.00
Sep 30, 2021 70,000.00
API Access

Nuvation Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NUVB&period=max&api_key=YOUR_API_KEY